Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
US Department of Justice
Moodys
Teva
Baxter
Medtronic
Argus Health
Chinese Patent Office

Generated: October 23, 2018

DrugPatentWatch Database Preview

AVENTYL Drug Profile

« Back to Dashboard

When do Aventyl patents expire, and when can generic versions of Aventyl launch?

Aventyl is a drug marketed by Ranbaxy and Lilly and is included in two NDAs.

The generic ingredient in AVENTYL is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

Summary for AVENTYL
Drug patent expirations by year for AVENTYL
Medical Subject Heading (MeSH) Categories for AVENTYL
Synonyms for AVENTYL
(2)10,d]cycloheptene-.delta.5.gamma.-propylamine, hydrochloride
00FN6IH15D
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methyl-, hydrochloride
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[ a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride
1-Propanamine,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride
10,11-Dihydro-5-(N-methyl-3-aminopropylidene)-5H-dibenzo[a,d]cycloheptene Hydrochloride
10,11-Dihydro-N-methyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine hydrochloride
3-(10,11-2H-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methyl-1-propanaminium chloride
3-(10,11-Dihydro-5H-dibenzo[a,d]-cyclohepten-5-ylidene)-N-methyl-1-propanamine
3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine Hydrochloride
3-(5,6-dihydrodibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-N-methylpropan-1-amine;hydrochloride
37025-22-2
5-(3-(Methylamino)propylidene)dibenzo(a,e)cyclohepta(1,5)diene hydrochloride
5-(3-Methylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene hydrochloride
5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride
5-[3-(Methylamino)propylidene]dibenzo[a,5]diene hydrochloride
5H-Dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine, 10-11-dihydro-N-methyl-, hydrochloride
5H-Dibenzo[a,.gamma.-propylamine, 10-11-dihydro-N-methyl-, hydrochloride
5H-Dibenzo[a,.gamma.-propylamine, 10,11-dihydro-N-methyl-, hydrochloride
72-69-5 (free base)
8057-32-7
894-71-3
AC1L9B17
AC1Q3BS4
Acetexa
AKOS015889095
Allegron
Altilev
AOB5370
API0003634
Ateben hydrochloride
Aventyl allegron
Aventyl hydrochloride
BG0274
C-46080
CAS-894-71-3
CCG-212718
CHEBI:7641
CHEMBL1201156
CPD000058486
CS-4913
CTK8G2012
D00816
Desmethylamitriptyline hydrochloride
DSSTox_CID_25109
DSSTox_GSID_45109
DSSTox_RID_80676
DTXSID2045109
EINECS 212-973-0
EN300-26665
EU-0100868
FT-0673146
HMS1568D10
HY-B1417
I01-17298
KS-000017PT
KS-1306
Lilly 38489
LP00868
methyl(3-{tricyclo[9.4.0.0?,?]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine hydrochloride
METHYL(3-{TRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YLIDENE}PROPYL)AMINE HYDROCHLORIDE
MFCD00058024
MLS000069673
MLS001077267
MLS002222206
MLS006010656
MolPort-003-959-040
N 7048
N 7261
N-[3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl]-N-methylamine hydrochloride
N0957
NC00522
NCGC00014483-01
NCGC00094192-01
NCGC00094192-02
NCGC00261553-01
NE48409
Noramitriptyline hydrochloride
Nortab hydrochloride
Nortrilen
Nortriptylin hydrochloride
Nortriptyline (hydrochloride)
Nortriptyline for system suitability, European Pharmacopoeia (EP) Reference Standard
Nortriptyline Hcl
Nortriptyline hdrochloride
Nortriptyline hydrochloride
Nortriptyline hydrochloride (JP17/USP/INN)
Nortriptyline hydrochloride [USAN:USP:JAN]
Nortriptyline Hydrochloride 1.0 mg/ml in Methanol (as free base)
Nortriptyline hydrochloride, >=98% (TLC), powder
Nortriptyline hydrochloride, British Pharmacopoeia (BP) Reference Standard
Nortriptyline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Nortriptyline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Nortriptyline monohydrochloride
NORTRIPTYLINEHYDROCHLORIDE
Norzepine
NSC 169453
NSC 78248
NSC-169453
NSC-78248
NSC169453
NSC78248
Opera_ID_1915
Pamelor
Pamelor (TN)
Pamelor hydrochloride
PL049963
Prestwick_366
Psychostyl
REGID_for_CID_441358
SAM002554915
SCHEMBL41329
Sensival
SHAYBENGXDALFF-UHFFFAOYSA-N
SMR000058486
SR-01000000223
SR-01000000223-2
Tox21_110048
Tox21_500868
UNII-00FN6IH15D
Vividyl
W-109609
WLN: L C676 BY&T&J BU3M1 &GH

US Patents and Regulatory Information for AVENTYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
US Department of Justice
Moodys
Teva
Baxter
Medtronic
Argus Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.